-
Director, Advanced Practice Provider (APP) Initiatives
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...6 days ago on The Resumator -
Clinical Safety and Medical Operations Manager
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...1 week ago on The Resumator -
Principal AIML Operations Engineer
Engineering · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...1 week ago on The Resumator -
Director, Global Health Economic and Outcomes Research (GHEOR)
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...1 week ago on The Resumator -
Associate Director, Specialty and Trade Operations
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...1 week ago on The Resumator -
Sr. Director Pharmacovigilance Compliance
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...1 week ago on The Resumator -
VP, Scientific Communications
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...1 week ago on The Resumator -
Senior Director, Commercial Data Strategy & Management
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...2 weeks ago on The Resumator -
Associate Director, Medical Information
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...2 weeks ago on The Resumator -
Senior Analyst, Commercial Analytics
Jobs · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...2 weeks ago on The Resumator -
Director, Global Strategy and Forecasting
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...3 weeks ago on The Resumator -
Associate Director, Global Market Research
Marketing/PR · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...3 weeks ago on The Resumator -
Senior Director, Regulatory Affairs, Advertising and Promotion
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...Over 4 weeks ago on The Resumator -
Director, Regulatory Strategy
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...Over 4 weeks ago on The Resumator -
Director, Regulatory Labeling
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...Over 4 weeks ago on The Resumator